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colour to bacterial load in acute exacerbations of
COPDThe recent study by Bresse-Keizer et al.1 dismisses all of
the work and opinion of other research groups with
a single concluding line in the abstract. This conclusion is
based on a small study of 22 patients admitted with an
exacerbation and purulent sputum (although Figure 2
indicates some had mucoid sputum). 23% were on antibi-
otics which will potentially reduce the viable organism
numbers, and 68% had antibiotics in the 4 weeks prior to
admission, although it is not clear if this was for a purulent
episode, whether it persisted or cleared temporarily.
These are all critical factors in determining whether these
were episodes of (a) new or increased purulence, (b) due
to resistant bacteria or (c) patients treated with the wrong
antibiotics. On admission we know nothing about the
bacteria, their sensitivities, any antibiotic therapy and
dose of corticosteroids, as it is referred to as ‘‘the hospital
protocol’’. The patients had no change in bacterial load or
sputum purulence during the admission. Load and puru-
lence grade did not correlate, although load and MPO (the
green protein) did, so it should be expected load and
colour would also correlate. The range of purulence is not
given and unless this covers a reasonable range a lack of
correlation means little, especially with such small
numbers. Nevertheless the presence of purulence and
a significant bacterial load is consistent with all the theory
and fact outlined by others.2,3 However, the lack of
change in purulence or load suggests treatment did not
include antibiotics or the choice and dose was incorrect. If
the patients improved clinically it must reflect other
symptoms and presumably other treatment or natural
recovery. If so the patients were discharged with purulent
sputum which may be their usual clinical state perhaps due
to the presence of Bronchiectasis.4 Determining the pres-
ence of an infective exacerbation in such patients is more
complex unless the purulent nature of the sputum has
clearly worsened.
Choosing antibiotics to manage exacerbations of COPD
has been best addressed by the classical study ofDOI of original article: 10.1016/j.rmed.2008.10.012.
0954-6111/$ - see front matter ª 2009 Elsevier Ltd. All rights reserved
doi:10.1016/j.rmed.2009.02.012Anthonisen et al.5 who demonstrated that clinical benefit
was only seen if all 3 major symptoms of increased
breathlessness, new or increased sputum production and
NEW OR INCREASED sputum purulence were present. Of
these, NEW OR INCREASED purulence (reflecting a visible
change in neutrophil recruitment) seems the most physio-
logically sensitive marker of a NEW OR INCREASED microbial
load and has been incorporated into all recent COPD
guidelines and this was the rationale for our previous
study.6
We feel that the current study lacks sufficient clinical,
microbiological, radiological and biochemical stringency in
a highly selected small number of patients to make
a conclusion that negates many years of careful scientific
method, peer review and clinical observation by other
groups. Finally, it should also be noted that although the 9
point chart is more scientific, in clinical practice a 5-point
scale is easier for patient and doctor clinical decision
making and shows rapid resolution with appropriate
antibiotics.7Conflict of interest
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